A Study Using Swedish Registries to Find Out How Many People With Type 2 Diabetes Had Cardiovascular Disease and Started Treatment With Empagliflozin Between 2015 and 2017
- Status
- COMPLETED
- Phase
- N/A
Related studies linked through entity extraction aliases.